EDITH STEELE: Open Payments
NPI 1225466758 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 24 payments from 15 companies in 2025. Trend: 2023 $971 · 2024 $854 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Novo Nordisk Inc | 3 | $65 |
| Lilly USA, LLC | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Averitas Pharma Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: AIRSUPRA, GEMTESA, Ozempic, BREZTRI, QUTENZA, CAPLYTA, MOUNJARO, INGREZZA.
Industry payments across TN — which companies pay providers there.
